346 related articles for article (PubMed ID: 2834938)
1. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
Levenson J; Chau NP; Billaud E; Simon A
Am J Cardiol; 1988 May; 61(13):1056-60. PubMed ID: 2834938
[TBL] [Abstract][Full Text] [Related]
2. Brachial artery hemodynamic response to acute converting enzyme inhibition by enalaprilat in essential hypertension.
Simon AC; Chau NP; Levenson J
Clin Pharmacol Ther; 1988 Jan; 43(1):49-54. PubMed ID: 2826067
[TBL] [Abstract][Full Text] [Related]
3. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
Reams GP; Lal SM; Whalen JJ; Bauer JH
J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
[TBL] [Abstract][Full Text] [Related]
4. Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises.
Hirschl MM; Binder M; Bur A; Herkner H; Woisetschläger C; Bieglmayer C; Laggner AN
J Hum Hypertens; 1997 Mar; 11(3):177-83. PubMed ID: 9175570
[TBL] [Abstract][Full Text] [Related]
5. Angiotensinergic versus nonangiotensinergic hemodynamic effects of converting enzyme inhibition in patients with chronic heart failure. Assessment by acute renin and converting enzyme inhibition.
Kiowski W; Beermann J; Rickenbacher P; Haemmerli R; Thomas M; Burkart F; Meinertz T
Circulation; 1994 Dec; 90(6):2748-56. PubMed ID: 7994817
[TBL] [Abstract][Full Text] [Related]
6. The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study.
Jekell A; Kalani M; Kahan T
Heart Vessels; 2017 Jun; 32(6):674-684. PubMed ID: 27885499
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.
Gardner SY; Atkins CE; Sams RA; Schwabenton AB; Papich MG
J Vet Intern Med; 2004; 18(2):231-7. PubMed ID: 15058776
[TBL] [Abstract][Full Text] [Related]
8. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
[TBL] [Abstract][Full Text] [Related]
9. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
12. Effect of enalaprilat on postoperative hypertension after surgical repair of coarctation of the aorta.
Rouine-Rapp K; Mello DM; Hanley FL; Mohan Reddy V; Soifer S
Pediatr Crit Care Med; 2003 Jul; 4(3):327-32. PubMed ID: 12831415
[TBL] [Abstract][Full Text] [Related]
13. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
Dahlöf B; Herlitz H; Aurell M; Hansson L
Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
Tunny TJ; Klemm SA; Hamlet SM; Gordon RD
J Urol; 1988 Oct; 140(4):713-5. PubMed ID: 2843688
[TBL] [Abstract][Full Text] [Related]
16. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
Ajayi AA; Hockings N; Reid JL
Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
[TBL] [Abstract][Full Text] [Related]
17. Serum angiotensin converting enzyme activity and response to angiotensin I in horses.
Tillman LG; Moore JN
Equine Vet J Suppl; 1989 Jun; (7):80-3. PubMed ID: 9118114
[TBL] [Abstract][Full Text] [Related]
18. The effect of renin-angiotensin system blockade on visceral blood flow during and after thoracic aortic cross-clamping.
Joob AW; Harman PK; Kaiser DL; Kron IL
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):411-8. PubMed ID: 3005777
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition and brachial artery haemodynamics in hypertension.
Simon AC; Levenson JA; Safar AM; Bouthier JD; Safar ME
Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):243S-247S. PubMed ID: 6099739
[TBL] [Abstract][Full Text] [Related]
20. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
Jackson B; Cubela R; Johnston CI
J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
